High-intensity focused ultrasound (HIFU) ablation versus surgical interventions for the treatment of symptomatic uterine fibroids: a meta-analysis
Authors:
- 1 August 2021
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 32 (2) , 1195-1204
Abstract
Objectives To compare the treatment success and safety of ultrasound- and MR-guided high-intensity focused ultrasound (HIFU) with surgery for treating symptomatic uterine fibroids. Methods We searched studies comparing HIFU with surgery for fibroids in different databases from January 2000 to July 2020. The mean difference (MD) or relative risk (RR) with 95% confidence interval (CI) for different outcome parameters was synthesized. Results We included 10 studies involving 4450 women. Compared with the surgery group, the decrease in uterine fibroid severity score at 6- and 12-month follow-up was higher in the HIFU group (MD − 4.16, 95% CI − 7.39 to − 0.94, and MD − 2.44, 95% CI − 3.67 to − 1.20, p < 0.05). The increase in quality-of-life (QoL) score at 6- and 12-month follow-up was higher in the HIFU group (MD 2.13, 95% CI 0.86 to 3.14, and MD 2.34, 95% CI 0.82 to 3.85, p < 0.05). The duration of hospital stay and the time to return to work was shorter in the HIFU group (MD − 3.41 days, 95% CI − 5.11 to − 1.70, and MD − 11.61 days, 95% CI − 19.73 to − 3.50, p < 0.05). The incidence of significant complications was lower in the HIFU group (RR 0.33, 95% CI 0.13 to 0.81, p < 0.05). The differences in the outcomes of adverse events, symptom recurrence, re-intervention, and pregnancy were not statistically significant (p > 0.05). Conclusions HIFU is superior to surgery in terms of symptomatic relief, improvement in QoL, recovery, and significant complications. However, HIFU showed comparable effects to surgery regarding the incidence of adverse events, symptom recurrence, re-intervention, and pregnancy. Key Points • HIFU ablation is superior to surgery in terms of symptomatic relief, improvement in QoL, recovery, and significant complications. • HIFU has comparable effects to surgery in terms of symptom recurrence rate, re-intervention rate, and pregnancy rate, indicating that HIFU is a promising non-invasive therapy that seems not to raise the risk of recurrence and re-intervention or deteriorate fertility compared to surgical approaches in women with fibroids. • There is still a lack of good-quality comparative data and further randomized studies are necessary to provide sufficient and reliable data, especially on re-intervention rate and pregnancy outcome.Keywords
This publication has 49 references indexed in Scilit:
- Magnetic resonance-guided focused ultrasound surgery (MRgFUS) treatment for uterine fibroidsBiomedical Imaging and Intervention Journal, 2010
- Magnetic resonance‐guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomasUltrasound in Obstetrics & Gynecology, 2009
- Society of Interventional Radiology Clinical Practice GuidelinesJournal of Vascular and Interventional Radiology, 2009
- Myomas and reproductive functionFertility and Sterility, 2008
- Uterine Leiomyomas: MR Imaging–guided Focused Ultrasound Surgery—Imaging Predictors of SuccessRadiology, 2008
- The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL)Health and Quality of Life Outcomes, 2008
- Sustained Relief of Leiomyoma Symptoms by Using Focused Ultrasound SurgeryObstetrics & Gynecology, 2007
- Health care resource use for uterine fibroid tumors in the United StatesAmerican Journal of Obstetrics and Gynecology, 2006
- Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experienceUltrasound in Medicine & Biology, 2004
- The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomataObstetrics & Gynecology, 2002